TEST:

K-TRACK™

''Gene Solutions has announced major upgrades to their K-TRACK and K-4CARE portfolios, reinforcing their commitment to making precision oncology more practical and more accessible in real-world care. With more than 20,000 K-TRACK, K-4CARE tests performed across leading cancer centers, the company has seen the growing clinical relevance of comprehensive genomic, transcriptomic profiling (CGP, CGTP) and molecular residual disease (MRD) monitoring in helping doctors guide treatment decisions and follow patients over time.''

''Gene Solutions presented real-world data on K-TRACK, a novel hybrid circulating tumor DNA (ctDNA) testing approach. This integrative method, combining tumor-informed and tumor-agnostic approach, addresses a critical gap in precision oncology: the challenge of obtaining high-quality tissue specimens in diverse clinical settings.''